Insider: Murphy Matthew B. General Counsel - Nautilus Biotechnology, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 74,140 | 74,140 | |
| Value | $ | $60,950.49 | $60,950.49 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 09/04/2025 | AAP | 20,000 | Indirect | COM | $0.64 | $12,858.00 | 74,140 |
| 08/15/2022 | AAP | 7,500 | Indirect | COM | $2.84 | $21,307.50 | 54,140 |
| 08/12/2022 | AAP | 2,500 | Indirect | COM | $2.85 | $7,125.00 | 46,640 |
| 08/13/2021 | AAP | 5,000 | Indirect | COM | $7.56 | $37,806.50 | 34,140 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research